Meiji Yasuda Life Insurance’s AbbVie ABBV Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.82M	Sell	22,176 -90	-0.4%	-$20K	0.16%	22
2025 Q4	$5.09M	Sell	22,266 -506	-2%	-$115K	0.15%	23
2025 Q3	$5.27M	Buy	22,772 +418	+2%	+$85.1K	0.15%	23
2025 Q2	$4.15M	Sell	22,354 -664	-3%	-$123K	0.12%	32
2025 Q1	$4.82M	Sell	23,018 -967	-4%	-$188K	0.1%	65
2024 Q4	$4.26M	Buy	23,985 +1,240	+5%	+$228K	0.08%	64
2024 Q3	$4.49M	Buy	22,745 +798	+4%	+$149K	0.08%	60
2024 Q2	$3.76M	Sell	21,947 -45,074	-67%	-$7.47M	0.08%	71
2024 Q1	$12.2M	Buy	67,021 +9,198	+16%	+$1.59M	0.26%	33
2023 Q4	$8.96M	Buy	57,823 +13,522	+31%	+$1.97M	0.19%	31
2023 Q3	$6.6M	Buy	44,301 +8,593	+24%	+$1.26M	0.18%	32
2023 Q2	$4.81M	Buy	35,708 +1,668	+5%	+$245K	0.13%	37
2023 Q1	$5.42M	Buy	34,040 +147	+0.4%	+$22.5K	0.11%	31
2022 Q4	$5.48M	Buy	33,893 +502	+2%	+$77K	0.12%	28
2022 Q3	$4.48M	Buy	33,391 +5,626	+20%	+$807K	0.1%	34
2022 Q2	$4.25M	Buy	27,765 +6,792	+32%	+$1.04M	0.07%	33
2022 Q1	$3.4M	Buy	20,973 +310	+2%	+$45K	0.06%	43
2021 Q4	$2.8M	Sell	20,663 -3,569	-15%	-$422K	0.05%	54
2021 Q3	$2.61M	Sell	24,232 -597	-2%	-$68.2K	0.05%	64
2021 Q2	$2.8M	Buy	24,829 +41	+0.2%	+$4.62K	0.05%	59
2021 Q1	$2.68M	Sell	24,788 -3,826	-13%	-$409K	0.05%	55
2020 Q4	$3.07M	Sell	28,614 -7,901	-22%	-$759K	0.05%	42
2020 Q3	$3.2M	Sell	36,515 -2,209	-6%	-$208K	0.06%	50
2020 Q2	$3.8M	Buy	38,724 +385	+1%	+$33.9K	0.15%	34
2020 Q1	$2.92M	Sell	38,339 -5,002	-12%	-$426K	0.58%	35
2019 Q4	$3.84M	Sell	43,341 -2,031	-4%	-$169K	0.52%	36
2019 Q3	$3.44M	Buy	45,372 +2,570	+6%	+$176K	0.49%	43
2019 Q2	$3.11M	Sell	42,802 -1,164	-3%	-$91.5K	0.46%	43
2019 Q1	$3.54M	Sell	43,966 -5,966	-12%	-$488K	0.54%	37
2018 Q4	$4.6M	Sell	49,932 -3,355	-6%	-$295K	0.71%	21
2018 Q3	$5.04M	Buy	53,287 +685	+1%	+$65K	0.63%	26
2018 Q2	$4.87M	Buy	52,602 +4,607	+10%	+$450K	0.67%	23
2018 Q1	$4.54M	Sell	47,995 -4,891	-9%	-$537K	0.7%	19
2017 Q4	$5.12M	Sell	52,886 -430	-0.8%	-$40.5K	0.71%	21
2017 Q3	$4.74M	Sell	53,316 -100	-0.2%	-$7.61K	0.7%	21
2017 Q2	$3.87M	Sell	53,416 -900	-2%	-$60.5K	0.6%	29
2017 Q1	$3.54M	Buy	54,316 +500	+0.9%	+$31.4K	0.56%	32
2016 Q4	$3.37M	Sell	53,816 -4,290	-7%	-$262K	0.56%	31
2016 Q3	$3.67M	Sell	58,106 -4,110	-7%	-$266K	0.49%	47
2016 Q2	$3.85M	Sell	62,216 -1,220	-2%	-$74.3K	0.61%	36
2016 Q1	$3.62M	Buy	63,436 +7,240	+13%	+$404K	0.57%	39
2015 Q4	$3.33M	Sell	56,196 -5,440	-9%	-$313K	0.53%	43
2015 Q3	$3.35M	Buy	61,636 +5,700	+10%	+$371K	0.56%	42
2015 Q2	$3.76M	Sell	55,936 -4,370	-7%	-$285K	0.58%	36
2015 Q1	$3.53M	Buy	60,306 +3,100	+5%	+$187K	0.55%	41
2014 Q4	$3.74M	Buy	57,206 +3,050	+6%	+$192K	0.55%	33
2014 Q3	$3.13M	Sell	54,156 -2,899	-5%	-$161K	0.48%	41
2014 Q2	$3.22M	Buy	57,055 +5,301	+10%	+$278K	0.51%	38
2014 Q1	$2.66M	Sell	51,754 -6,764	-12%	-$342K	0.46%	44
2013 Q4	$3.09M	Sell	58,518 -1,700	-3%	-$83.6K	0.52%	41
2013 Q3	$2.69M	Sell	60,218 -3,871	-6%	-$172K	0.49%	42
2013 Q2	$2.65M	Buy	+64,089	New	+$2.8M	0.49%	41

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meiji Yasuda Life Insurance's ABBV Position: Q1 2026 in Review

Meiji Yasuda Life Insurance reduced its AbbVie (ABBV) stake by 0.4% in Q1 2026, selling an estimated $20K and leaving 22,176 shares worth $4.82M. The position accounts for 0.16% of the portfolio, ranked #22.

Meiji Yasuda Life Insurance first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.2M in Q1 2024. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Meiji Yasuda Life Insurance held 22,176 shares of AbbVie worth $4.82M as of Q1 2026.
Meiji Yasuda Life Insurance sold 90 AbbVie shares in Q1 2026, an estimated $20K.
AbbVie made up 0.16% of Meiji Yasuda Life Insurance's portfolio in Q1 2026, its #22 holding.
Meiji Yasuda Life Insurance first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Meiji Yasuda Life Insurance's AbbVie position peaked at $12.2M in Q1 2024.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.